Japan secures 120 mn doses of potential corona-vaccine: pharma group

Japan has signed a deal to secure 120 million doses of a potential coronavirus vaccine, German pharmaceutical group BioNTech, which is developing the drug with US pharma giant Pfizer, said Friday. Financial details of the deal were not disclosed, with BioNTech saying the terms were based on the timing of the delivery and volume of doses.